Last reviewed · How we verify

NCT05274399

Hopelessness and Self-care Power in Hemodialysis Patients

Completed Last updated 28 March 2023
What this trial tests

trial testing surveys and questionnaires in Hemodialysis in 1 participant. Completed in 20 October 2020.

Timeline
14 February 2020
Primary endpoint
10 May 2020
20 October 2020

Quick facts

Lead sponsorMuş Alparslan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1
Start date14 February 2020
Primary completion10 May 2020
Estimated completion20 October 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Muş Alparslan University

Who can join

18 and older, any sex, with Hemodialysis or Despondency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the correlation between hopelessness level and self-care agency in patient receiving hemodialysis treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of surveys and questionnaires

Trials testing the same drug.

Other recruiting trials for Hemodialysis

Currently open trials in the same condition.

Other Muş Alparslan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05274399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing